Shilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Meeting of the Board of Directors ....
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shilpa Medicare has informed BSE that its Board of Directors will meet on 13 August 2025 to consider and approve a proposal for the issue of bonus shares, subject to necessary approvals. The company has also noted that the trading window for dealing in its securities is already closed from 1 July 2025 and will remain closed until 48 hours after the declaration of unaudited financial results for Q1 FY26, which is expected by 15 August 2025. No specific bonus ratio, record date, or other financial details have been disclosed in this intimation. The announcement is regulatory in nature and precedes the actual decision.
This is a forward-looking intimation, not a confirmed action. If the Board approves a bonus issue on 13 August, it could be viewed positively by retail investors as it typically increases share liquidity. Until the ratio and terms are announced, there is no immediate impact on the stock price or shareholder action required.